Trial Profile
An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ambroxol (Primary)
- Indications Gaucher's disease type I
- Focus Adverse reactions
- Sponsors ExSAR
- 16 Apr 2014 New trial record